Cite
HARVARD Citation
Yoo, D. et al. (2014). THU0159 Disease Activity Assessment Using the DAS28, CDAI and SDAI and Effect of Anti-Drug Antibody on Clinical Response in a Randomized, Double-Blind, Comparative Trial of CT-P13 and Innovator Infliximab: Planetra Study. Annals of the rheumatic diseases. p. 235. [Online].